A citation-based method for searching scientific literature

Suzanne Craft, G Stennis Watson. Lancet Neurol 2004
Times Cited: 588







List of co-cited articles
765 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.
Steven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, Aaron M Koenig, Hoau-Yan Wang, Rexford S Ahima, Suzanne Craft, Sam Gandy, Christoph Buettner, Luke E Stoeckel,[...]. Nat Rev Neurol 2018
552
16

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Li-Ying Han, Kalindi P Bakshi, Andres Stucky, Robert L Fuino, Krista R Kawaguchi, Andrew J Samoyedny, Robert S Wilson,[...]. J Clin Invest 2012
16

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Suzanne Craft, Laura D Baker, Thomas J Montine, Satoshi Minoshima, G Stennis Watson, Amy Claxton, Matthew Arbuckle, Maureen Callaghan, Elaine Tsai, Stephen R Plymate,[...]. Arch Neurol 2012
842
13

Intranasal insulin improves memory in humans.
Christian Benedict, Manfred Hallschmid, Astrid Hatke, Bernd Schultes, Horst L Fehm, Jan Born, Werner Kern. Psychoneuroendocrinology 2004
501
12

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
M A Reger, G S Watson, P S Green, C W Wilkinson, L D Baker, B Cholerton, M A Fishel, S R Plymate, J C S Breitner, W DeGroodt,[...]. Neurology 2008
571
11

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
Enrique J Rivera, Alison Goldin, Noah Fulmer, Rose Tavares, Jack R Wands, Suzanne M de la Monte. J Alzheimers Dis 2005
517
10

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Eric Steen, Benjamin M Terry, Enrique J Rivera, Jennifer L Cannon, Thomas R Neely, Rose Tavares, X Julia Xu, Jack R Wands, Suzanne M de la Monte. J Alzheimers Dis 2005
10

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
Theresa R Bomfim, Leticia Forny-Germano, Luciana B Sathler, Jordano Brito-Moreira, Jean-Christophe Houzel, Helena Decker, Michael A Silverman, Hala Kazi, Helen M Melo, Paula L McClean,[...]. J Clin Invest 2012
594
9

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
361
9

Diabetes mellitus and the risk of dementia: The Rotterdam Study.
A Ott, R P Stolk, F van Harskamp, H A Pols, A Hofman, M M Breteler. Neurology 1999
9

Alzheimer's disease is type 3 diabetes-evidence reviewed.
Suzanne M de la Monte, Jack R Wands. J Diabetes Sci Technol 2008
592
8

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.
M A Reger, G S Watson, W H Frey, L D Baker, B Cholerton, M L Keeling, D A Belongia, M A Fishel, S R Plymate, G D Schellenberg,[...]. Neurobiol Aging 2006
463
8

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
Amy Claxton, Laura D Baker, Angela Hanson, Emily H Trittschuh, Brenna Cholerton, Amy Morgan, Maureen Callaghan, Matthew Arbuckle, Colin Behl, Suzanne Craft. J Alzheimers Dis 2015
252
8

Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
99
8

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
Mark A Reger, G Stennis Watson, Pattie S Green, Laura D Baker, Brenna Cholerton, Mark A Fishel, Stephen R Plymate, Monique M Cherrier, Gerard D Schellenberg, William H Frey,[...]. J Alzheimers Dis 2008
377
8

The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study.
Emma M Bingham, David Hopkins, Diarmuid Smith, Andrew Pernet, William Hallett, Laurence Reed, Paul K Marsden, Stephanie A Amiel. Diabetes 2002
213
7



Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease.
Enrique Blázquez, Esther Velázquez, Verónica Hurtado-Carneiro, Juan Miguel Ruiz-Albusac. Front Endocrinol (Lausanne) 2014
280
7

Hyperinsulinemia and risk of Alzheimer disease.
Jose A Luchsinger, Ming-Xin Tang, Steven Shea, Richard Mayeux. Neurology 2004
496
7

Insulin in the brain: there and back again.
William A Banks, Joshua B Owen, Michelle A Erickson. Pharmacol Ther 2012
324
7


Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Suzanne Craft, Amy Claxton, Laura D Baker, Angela J Hanson, Brenna Cholerton, Emily H Trittschuh, Deborah Dahl, Erin Caulder, Bryan Neth, Thomas J Montine,[...]. J Alzheimers Dis 2017
166
7

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
100
7

Role for neuronal insulin resistance in neurodegenerative diseases.
Markus Schubert, Dinesh Gautam, David Surjo, Kojihiko Ueki, Stephanie Baudler, Dominic Schubert, Tatsuya Kondo, Jens Alber, Norbert Galldiks, Eckehardt Küstermann,[...]. Proc Natl Acad Sci U S A 2004
472
6

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.
L Frölich, D Blum-Degen, H G Bernstein, S Engelsberger, J Humrich, S Laufer, D Muschner, A Thalheimer, A Türk, S Hoyer,[...]. J Neural Transm (Vienna) 1998
539
6



Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
Lap Ho, Weiping Qin, Patrick N Pompl, Zhongmin Xiang, Jun Wang, Zhong Zhao, Yuanzhen Peng, Gina Cambareri, Anne Rocher, Charles V Mobbs,[...]. FASEB J 2004
477
6

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.
Jessica Freiherr, Manfred Hallschmid, William H Frey, Yvonne F Brünner, Colin D Chapman, Christian Hölscher, Suzanne Craft, Fernanda G De Felice, Christian Benedict. CNS Drugs 2013
314
6

Insulin and the insulin receptor in experimental models of learning and memory.
Wei-Qin Zhao, Hui Chen, Michael J Quon, Daniel L Alkon. Eur J Pharmacol 2004
338
6


Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans.
Stephanie Kullmann, Martin Heni, Manfred Hallschmid, Andreas Fritsche, Hubert Preissl, Hans-Ulrich Häring. Physiol Rev 2016
255
6

Role of insulin and insulin receptor in learning and memory.
W Q Zhao, D L Alkon. Mol Cell Endocrinol 2001
360
6

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.
Fernanda G De Felice, Marcelo N N Vieira, Theresa R Bomfim, Helena Decker, Pauline T Velasco, Mary P Lambert, Kirsten L Viola, Wei-Qin Zhao, Sergio T Ferreira, William L Klein. Proc Natl Acad Sci U S A 2009
483
6


Intranasal insulin improves memory in humans: superiority of insulin aspart.
Christian Benedict, Manfred Hallschmid, Katrin Schmitz, Bernd Schultes, Frank Ratter, Horst L Fehm, Jan Born, Werner Kern. Neuropsychopharmacology 2007
208
6


Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
114
6

A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
Dong Seok Kim, Ho-Il Choi, Yun Wang, Yu Luo, Barry J Hoffer, Nigel H Greig. Cell Transplant 2017
76
7

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
139
6

Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Parkinsonism Relat Disord 2013
65
9


Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
Konstantinos Ioannis Avgerinos, Grigorios Kalaitzidis, Antonia Malli, Dimitrios Kalaitzoglou, Pavlos Gr Myserlis, Vasileios-Arsenios Lioutas. J Neurol 2018
61
8

Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.
Ramesh Kandimalla, Vani Thirumala, P Hemachandra Reddy. Biochim Biophys Acta Mol Basis Dis 2017
271
5

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Molly Stanley, Shannon L Macauley, David M Holtzman. J Exp Med 2016
116
5

Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
Laura D Baker, Donna J Cross, Satoshi Minoshima, Dana Belongia, G Stennis Watson, Suzanne Craft. Arch Neurol 2011
424
5

How does brain insulin resistance develop in Alzheimer's disease?
Fernanda G De Felice, Mychael V Lourenco, Sergio T Ferreira. Alzheimers Dement 2014
216
5




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.